DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

Status unconfirmed · Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DHA-paclitaxel in treating patients who have metastatic colorectal cancer.

Key facts

Study ID

NCT00024401

Run by

Theradex

Starts

2001-05-01

Last updated by the study team

2008-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arizona Oncology Associates — Tucson, Arizona, United States
• Veterans Affairs Medical Center - Washington, DC — Washington D.C., District of Columbia, United States
• Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
• Albert B. Chandler Medical Center, University of Kentucky — Lexington, Kentucky, United States
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
• Veterans Affairs Medical Center - East Orange — East Orange, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.